Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study

Background Mucormycosisis a rare but devastating fungal infection primarily affecting immunocompromised patients such as those with hematological malignancy, bone marrow and solid organ transplantation, and patients with diabetes, and, even more rarely, immunocompetentpatients. The objective of this study was to assess the prevalence and burden, both clinical and economic, of mucormycosisamong hospitalized patients in the U.S.